Zobrazeno 1 - 10
of 55
pro vyhledávání: '"John, Goodchild"'
Autor:
John Goodchild
Publikováno v:
Expert Opinion on Therapeutic Targets. 6:235-247
Expensive failures in the pharmaceutical industry might be avoided by target validation at an early stage. Often, the full consequences of inhibiting a chosen drug target do not emerge until late in the development process. One option is to use hamme
Autor:
Lina Prasmickaite, Øystein Fodstad, John Goodchild, Kristian Berg, Anders Høgset, Gunhild Mari Mælandsmo, Thomas A. Perkins, Eivind Hovig
Publikováno v:
Nucleic Acids Research. 26:4241-4248
The uptake and cellular metabolism of a fluorescein-labelled synthetic ribozyme stabilized by 2'- O -methyl modification and a 3' inverted thymidine have been studied, employing capillary gel electrophoresis as a novel and efficient analytical method
Publikováno v:
Biochemistry. 35:16370-16377
A defining characteristic of catalysts is the rate at which they can process multiple copies of substrate. In the case of synthetic hammerhead ribozymes that cleave an RNA sequence, binding of the ribozyme to the substrate and products is through bas
Autor:
John Goodchild, A. Kirk Field
Publikováno v:
Expert Opinion on Investigational Drugs. 4:799-821
During the seventeen years since the Zamecnik and Stephenson report [77] of antisense oligonucleotide activity, the literature describing efficacy in cell culture and animals has mushroomed. The technology has become far more sophisticated with the a
Publikováno v:
Nucleic Acids Research. 22:632-638
Approximately 80% of the DNA ligase activity in HeLa cell extracts is associated with the 21 S enzyme complex that functions in simian virus 40 DNA replication in vitro (Malkas et al., Biochemistry 29, 6362-6374., 1990). The DNA ligase associated wit
Autor:
John Goodchild
Publikováno v:
Methods in Molecular Biology ISBN: 9781617791871
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6adb5bc4c1d4964e1169f43ca7b653eb
https://doi.org/10.1007/978-1-61779-188-8_1
https://doi.org/10.1007/978-1-61779-188-8_1
Autor:
John Goodchild
Publikováno v:
Nucleic Acids Research. 20:4607-4612
RNA catalysts (ribozymes) designed to cleave sequences unique to viral RNA's might be developed as therapeutics. For this purpose, they would require high catalytic efficiency and resistance to nucleases. Reported here are two approaches that can be
Publikováno v:
British Journal of Theological Education. 4:48-53
Publikováno v:
Antisense Research and Development. 1:153-160
A 32P-labeled oligodeoxynucleotide of 20 bases was found to be quite stable in freshly drawn rabbit or human blood and no degradation was apparent within 2 hr. In contrast, following injection into rabbits, the same oligodeoxynucleotide was cleared f
Autor:
John, Goodchild
Publikováno v:
Current opinion in molecular therapeutics. 10(2)